Publications by authors named "Xavier Charest-Morin"

Claim this Profile
R
Regulation of the Expression, Oligomerisation and Signaling of the Inhibitory Receptor CLEC12A by Cysteine Residues in the Stalk Region.
Julien Vitry, Guillaume Paré, Andréa Murru, Xavier Charest-Morin, Halim Maaroufi

Int J Mol Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Modeling of Bradykinin-Mediated Angioedema States.
François Marceau, Hélène Bachelard, Xavier Charest-Morin, Jacques Hébert, Georges E Rivard

Pharmaceuticals (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Pharmacological Profile of a New Small Molecule Bradykinin B Receptor Antagonist.
Anne Lesage, Christoph Gibson, François Marceau, Horst-Dieter Ambrosi, Jörn Saupe, Xavier Charest-Morin

Front Pharmacol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation.
François Marceau, Hélène Bachelard, Johanne Bouthillier, Jean-Philippe Fortin, Guillaume Morissette, Xavier Charest-Morin

Int Immunopharmacol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency.
Xavier Charest-Morin, Jacques Hébert, Georges-Étienne Rivard, Arnaud Bonnefoy, Eric Wagner

Front Immunol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diagnosis of hereditary angioedema with C1 inhibitor deficiency: a survey of Canadian physicians and laboratories.
Xavier Charest-Morin, Stephen Betschel, Rozita Borici-Mazi, Amin Kanani, Gina Lacuesta

Allergy Asthma Clin Immunol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bifunctional ligands of the bradykinin B and B receptors: An exercise in peptide hormone plasticity.
François Marceau, Marie-Thérèse Bawolak, Jean-Philippe Fortin, Guillaume Morissette, Caroline Roy, Xavier Charest-Morin

Peptides· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bifunctional fusion proteins containing the sequence of the bradykinin homologue maximakinin: activities at the rat bradykinin B receptor.
Xavier Charest-Morin, Robert Lodge, François Marceau

Can J Physiol Pharmacol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-Arg-Bradykinin-Arg-Arg, a Latent Vasoactive Bradykinin B Receptor Agonist Metabolically Activated by Carboxypeptidases.
Hélène Bachelard, Xavier Charest-Morin, François Marceau

Front Pharmacol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production and evaluation of parathyroid hormone receptor ligands with intrinsic or assembled peroxidase domains.
Xavier Charest-Morin, Patrice E Poubelle, François Marceau

Sci Rep· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells.
Sébastien Fortin, Xavier Charest-Morin, Vanessa Turcotte, Coraline Lauvaux, Jacques Lacroix

J Med Chem· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B receptor and peptidase resistance in rats.
Xavier Charest-Morin, Hélène Bachelard, Melissa Jean, Francois Marceau

PeerJ· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infrared-emitting, peptidase-resistant fluorescent ligands of the bradykinin B receptor: application to cytofluorometry and imaging.
Lajos Gera, Xavier Charest-Morin, Melissa Jean, Hélène Bachelard, François Marceau

BMC Res Notes· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biotechnological Fluorescent Ligands of the Bradykinin B1 Receptor: Protein Ligands for a Peptide Receptor.
Xavier Charest-Morin, François Marceau

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The isolated human umbilical vein as a bioassay for kinin-generating proteases: An in vitro model for therapeutic angioedema agents.
Melissa Jean, Arvind Raghavan, Matthew L Charles, Mark S Robbins, Eric Wagner, Xavier Charest-Morin

Life Sci· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Effects of Bradykinin B2 Receptor Agonists with Varying Susceptibility to Peptidases.
Mélissa Jean, Lajos Gera, Xavier Charest-Morin, François Marceau, Hélène Bachelard

Front Pharmacol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autophagic flux inhibition and lysosomogenesis ensuing cellular capture and retention of the cationic drug quinacrine in murine models.
Alexandre Parks, Xavier Charest-Morin, Michael Boivin-Welch, Johanne Bouthillier, Francois Marceau

PeerJ· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological profile of a bifunctional ligand of the formyl peptide receptor1 fused to the myc epitope.
Xavier Charest-Morin, Caroline Roy, Maria J G Fernandes, François Marceau

Int Immunopharmacol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological effects of recombinant human tissue kallikrein on bradykinin B2 receptors.
Xavier Charest-Morin, Arvind Raghavan, Matthew L Charles, Tadeusz Kolodka, Johanne Bouthillier

Pharmacol Res Perspect· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tagged parathyroid hormone derivative as a carrier of antibody cargoes transported by the G protein coupled PTH1 receptor.
Xavier Charest-Morin, Jean-Philippe Fortin, Robert Lodge, Isabelle Allaeys, Patrice E Poubelle

Peptides· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase-activated B2 receptor agonists.
Xavier Charest-Morin, Caroline Roy, Emile-Jacques Fortin, Johanne Bouthillier, François Marceau

Front Pharmacol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasopeptidase-activated latent ligands of the histamine receptor-1.
Lajos Gera, Caroline Roy, Xavier Charest-Morin, François Marceau

Int Immunopharmacol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Green fluorescent protein fused to peptide agonists of two dissimilar G protein-coupled receptors: novel ligands of the bradykinin B2 (rhodopsin family) receptor and parathyroid hormone PTH1 (secretin family) receptor.
Xavier Charest-Morin, Jean-Philippe Fortin, Marie-Thérèse Bawolak, Robert Lodge, François Marceau

Pharmacol Res Perspect· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-C chemokine receptor-7 mediated endocytosis of antibody cargoes into intact cells.
Xavier Charest-Morin, Rémy Pépin, Angélique Gagné-Henley, Guillaume Morissette, Robert Lodge

Front Pharmacol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory effects of cytoskeleton disrupting drugs and GDP-locked Rab mutants on bradykinin B₂ receptor cycling.
Xavier Charest-Morin, Sébastien Fortin, Robert Lodge, Caroline Roy, Lajos Gera

Pharmacol Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis